![Erik van Snippenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik van Snippenberg
Direktor/Vorstandsmitglied bei Eurovitegroup
Aktive Positionen von Erik van Snippenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Eurovitegroup | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Erik van Snippenberg
Ehemalige bekannte Positionen von Erik van Snippenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UDG HEALTHCARE PLC | Direktor/Vorstandsmitglied | 02.07.2018 | 01.11.2021 |
GlaxoSmithKline (Ireland) Ltd.
![]() GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Corporate Officer/Principal | - | - |
Statistik
International
Irland | 3 |
Niederlande | 2 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
UDG Healthcare Ltd. (Dublin)
![]() UDG Healthcare Ltd. (Dublin) Miscellaneous Commercial ServicesCommercial Services UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland. | Commercial Services |
Eurovitegroup | |
GlaxoSmithKline (Ireland) Ltd.
![]() GlaxoSmithKline (Ireland) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (Ireland) Ltd. is a company based in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Erik van Snippenberg
- Erfahrung